Transdermal fentanyl therapy for pains in children with infantile neuronal ceroid lipofuscinosis

European Journal of Paediatric Neurology

Volumn 5, Issue SUPPL. A, 2001, Pages 175-177

  Mannerkoski, M K ^a   Heiskala, H J ^a   Santavuori, P R A ^a   Pouttu, J A ^a  

^a Rinnekoti Foundation Finland   (Finland)

Author keywords

INCL; Pain; Transdermal fentanyl

Indexed keywords

FENTANYL; OPIATE;

ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DRUG BLOOD LEVEL; DRUG RELEASE; HUMAN; METABOLIC DISORDER; NEURONAL CEROID LIPOFUSCINOSIS; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL;

EID: 0034912416     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejpn.2001.0500     Document Type: Editorial

References (13)

1. CLN1. Infantile and other types of NCL with GROD
2. Infantile type of so-called neuronal ceroid-lipofuscinosis. Part 1
3. Infantile type of so-called neuronal ceroid-lipofuscinosis
4. Psychological symptoms and sleep disturbances in neuronal ceroid-lipofuscinoses (NCL)
5. MRI Evaluation of the brain in infantile neuronal ceroid-lipofuscinosis. Part 2: MRI findings in 21 Patients
6. Intravenous opioid anesthetics
7. Clinical pharmacokinetics of fentanyl and its newer derivatives
8. Absorption characteristics of transdermally administered fentanyl
9. (3H) Sufentanil, a superior ligand for μ-opiate receptors: Binding properties and regional distribution in rat brain and spinal cord
10. Measurement of pain in children with self-reporting and behavioral assessment
11. Magnetic resonance techniques in neuronal ceroid lipofuscinosis and some other lysosomal diseases affecting the brain
12. Transdermal fentanyl in children with cancer pain: Feasibility, tolerability and pharmacokinetic correlates
13. The use of transdermal fentanyl in a six-year-old patient with neuroblastoma and diffuse abdominal pain